Defence Therapeutics Inc (DTC.CX)
0.29
0.00 (0.00%)
CAD |
CNSX |
Nov 13, 16:00
Defence Therapeutics Price : 0.29 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 0.285 | 0.30 | 0.27 | 0.29 | 229867.0 |
| Nov 12, 2026 | 0.31 | 0.31 | 0.29 | 0.29 | 76500.00 |
| Nov 11, 2026 | 0.335 | 0.335 | 0.31 | 0.31 | 13000.00 |
| Nov 10, 2026 | 0.335 | 0.34 | 0.335 | 0.335 | 7000.00 |
| Nov 09, 2026 | 0.33 | 0.33 | 0.33 | 0.33 | 0.000 |
| Nov 06, 2026 | 0.37 | 0.37 | 0.33 | 0.355 | 18228.00 |
| Nov 05, 2026 | 0.345 | 0.37 | 0.33 | 0.35 | 44500.00 |
| Nov 04, 2026 | 0.32 | 0.34 | 0.32 | 0.335 | 6050.00 |
| Nov 03, 2026 | 0.30 | 0.345 | 0.30 | 0.34 | 68500.00 |
| Nov 02, 2026 | 0.35 | 0.35 | 0.285 | 0.285 | 109500.0 |
| Oct 30, 2026 | 0.355 | 0.355 | 0.35 | 0.35 | 40500.00 |
| Oct 29, 2026 | 0.36 | 0.36 | 0.35 | 0.35 | 39500.00 |
| Oct 28, 2026 | 0.37 | 0.37 | 0.35 | 0.35 | 4500.00 |
| Oct 27, 2026 | 0.37 | 0.37 | 0.37 | 0.37 | 0.000 |
| Oct 26, 2026 | 0.42 | 0.42 | 0.42 | 0.42 | 1500.00 |
| Oct 23, 2026 | 0.405 | 0.405 | 0.38 | 0.39 | 23200.00 |
| Oct 22, 2026 | 0.395 | 0.395 | 0.385 | 0.385 | 6833.00 |
| Oct 21, 2026 | 0.36 | 0.365 | 0.36 | 0.365 | 64000.00 |
| Oct 20, 2026 | 0.38 | 0.38 | 0.365 | 0.365 | 13100.00 |
| Oct 19, 2026 | 0.38 | 0.38 | 0.38 | 0.38 | 14694.00 |
| Oct 16, 2026 | 0.37 | 0.385 | 0.34 | 0.34 | 80600.00 |
| Oct 15, 2026 | 0.395 | 0.395 | 0.36 | 0.36 | 7675.00 |
| Oct 14, 2026 | 0.355 | 0.36 | 0.34 | 0.345 | 85509.00 |
| Oct 13, 2026 | 0.40 | 0.40 | 0.36 | 0.36 | 26390.00 |
| Oct 09, 2026 | 0.40 | 0.40 | 0.40 | 0.40 | 1000.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Spectral Medical, Inc. | 1.00 |
| Resverlogix Corp. | 0.075 |
| Theratechnologies, Inc. | 4.47 |
| COSCIENS Biopharma, Inc. | 8.32 |
| Restart Life Sciences Corp. | 0.065 |
Price Related Metrics
| PEG Ratio | -0.0479 |
| Price to Book Value | 6.262 |
| Earnings Yield | -38.03% |
| Market Cap | 21.98M |
| PEGY Ratio | -0.0479 |